Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Toxicology and Applied Pharmacology|November 1, 1988
Circadian time dependence of murine tolerance for carboplatinN A Boughattas, F Lévi, B Hecquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 1998
Irinotecan-induced immune thrombocytopeniaL Bozec, P Bierling, P Fromont, et al.
British Journal of Cancer|April 21, 2005
Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatinX M Li, K Tanaka, J Sun, et al.
Chronobiology International|January 1, 1984
Interindividual differences in a set of biological rhythms documented during the high arctic summer (79 degrees N) in three healthy subjectsA Reinberg, T Brossard, M F Andre, et al.
Annals of Surgery|October 1, 1996
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapyH Bismuth, R Adam, F Lévi, et al.
Chronobiologia|January 1, 1989
Internal desynchronization of circadian rhythms and tolerance of shift workA Reinberg, Y Motohashi, P Bourdeleau, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 20, 1998
Serum thymidine kinase levels are elevated and exhibit diurnal variations in patients with advanced ovarian cancerM Hallek, Y Touitou, F Lévi, et al.
Cancer Research|March 31, 2001
Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combinationT G Granda, E Filipski, R M D'Attino, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 6, 2000
Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F(1) miceX M Li, X H Liu, E Filipski, et al.
Biopharmaceutics & Drug Disposition|December 1, 1994
Comparative pharmacokinetics of oxaliplatin (L-OHP) and carboplatin (CBDCA) in mice with reference to circadian dosing timeN A Boughattas, B Hecquet, C Fournier, et al.
Pageof 12